{
  "catalogId": "24791336-b156-48b6-a861-6d07b5938eed",
  "name": "TALZENNA 0.25 MG",
  "status": "draft",
  "category": "prescription",
  "registrationValidity": "valid",
  "registrationNumber": "164 07 36019 00",
  "treatmentDescriptions": "TALZENNA is indicated for the treatment of adult patients with deleterious or suspected deleterious germline breast cancer susceptibility gene (BRCA) mutated (gBRCAm) human epidermal growth factor receptor 2 (HER2) negative locally advanced or metastatic breast cancer.",
  "termsOfIssue": "Prescription required",
  "form": "capsule, hard",
  "route": "per os",
  "site": "",
  "method": "",
  "administrationNotes": "",
  "ingredients": "TALAZOPARIB AS TOSYLATE 0.25  MG",
  "codes": {
    "atc5": {
      "system": "WHO ATC Classification",
      "code": "L01XX60",
      "name": "TALAZOPARIB"
    }
  },
  "contraindications": "",
  "sideEffect": "",
  "warnings": "תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת",
  "alternativeMedications": [],
  "packaging": [
    {
      "name": "TALZENNA 0.25 MG  30 CAPS",
      "manufacturer": {
        "name": "פיזר",
        "countryOfOrigin": "IL"
      },
      "strength": {
        "value": 0,
        "unit": ""
      },
      "quantity": {
        "value": 30.0,
        "unit": "units"
      },
      "packagingDescription": "BLISTER PVC/PVDC/ALUMINIUM",
      "shelfLife": "48",
      "storageConditions": "",
      "codes": {
        "moh": "8544",
        "yarpa": "548",
        "barcode": "7290013592620"
      },
      "manufacturersAdministrationRecommendation": "",
      "pricing": {
        "currency": "ILS",
        "maxWholesalePrice": 6096.140978,
        "retailMargin": 10.0,
        "maxRetailPrice": 6705.755075,
        "maxPriceWithVAT": 7912.790637
      }
    }
  ],
  "metadata": {
    "version": "1.4",
    "lastUpdated": "2025-07-31T22:09:11.830729"
  }
}